Study to Assess Efficacy and Safety of Bone Marrow Derived Stem Cells in Patients With Critical Limb Ischemia
Phase 2
Completed
- Conditions
- Critical Limb Ischemia
- Interventions
- Biological: ASCT01 (Autologous Stem Cell Transplantation)
- First Posted Date
- 2013-06-03
- Last Posted Date
- 2019-02-22
- Lead Sponsor
- Lifecells, LLC.
- Target Recruit Count
- 24
- Registration Number
- NCT01867190
- Locations
- 🇺🇸
Kansas City Vascular Foundation (KCV), North Kansas City, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath